Oestrogen sulphatase activity in hormone‐dependent and hormone‐independent breast‐cancer cells: Modulation by steroidal and non‐steroidal therapeutic agents
- 1 April 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 50 (6) , 901-905
- https://doi.org/10.1002/ijc.2910500614
Abstract
Oestrogen sulphatase may play an important role in providing intracellular oestrogens from E1S for the growth and maintenance of breast tumours. In this study, we characterized oestrogen sulphatase in the hormone‐dependent (ER/PR+) MCF‐7 and in the hormone‐independent (ER/PR ) MDA‐MB‐231 breast‐cancer cells and, furthermore, examined its modulation by MPA, 4‐OH‐A4, tamoxifen, danazol, ethinyloestradiol and DMAS in both these cell types. Our detailed study of oestrogen sulphatase activity as a function of incubation time, E1S concentration and numbers of MCF‐7 and MDA‐MB‐231 cells showed that more E1S was hydrolysed by MDA‐MB‐231 cells than by MCF‐7 cells at all time points and all substrate concentrations. Additionally, although the km values of E1S for oestrogen sulphatase in both MCF‐7 and MDA‐MB‐231 cells were similar, the Vmax values, and therefore the activity, differed greatly. The effect of various steroidal and non‐steroidal compounds also suggested differences in these 2 cell lines with respect to oestrogen sulphatase inhibition or stimulation. MPA significantly increased the hydrolysis of [3H]E1S in both cell lines, possibly through its effect on membrane fluidity. Tamoxifen increased E1S hydrolysis in MDA‐MB‐231 cells but not in MCF‐7 cells, whereas 4‐OH‐A4 inhibited E1S in MCF‐7 cells but not in MDA‐MB‐231 cells. Danazol (an isoxazol derivative of 17α‐ethinyltestosterone), 17α‐ethinyloestradiol and DMAS all significantly inhibited oestrogen sulphatase activity in both cell lines. Furthermore, danazol had a growth‐inhibitory effect on both MCF‐7 and MDA‐MB‐231 cells, although MCF‐7 cells appeared to be more sensitive to growth inhibition by danazol.Keywords
This publication has 18 references indexed in Scilit:
- Postmenopausal estrogen synthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancerJournal of Steroid Biochemistry, 1990
- A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17β‐hydroxysteroid dehydrogenase activityInternational Journal of Cancer, 1990
- Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimideBritish Journal of Cancer, 1989
- High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimenCancer, 1989
- Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studiesSteroids, 1987
- Aromatase inhibitors and their potential clinical significanceJournal of Steroid Biochemistry, 1986
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitroAmerican Journal of Obstetrics and Gynecology, 1986
- Inhibition of steroid sulfatase activity by danazolActa Obstetricia et Gynecologica Scandinavica, 1984
- THE RELATIONSHIP BETWEEN 17β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY AND OESTROGEN CONCENTRATIONS IN HUMAN BREAST TUMOURS AND IN NORMAL BREAST TISSUEClinical Endocrinology, 1983
- Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and femalesJournal of Clinical Investigation, 1968